Literature DB >> 22092022

Managed care and the diffusion of endoscopy in fee-for-service Medicare.

Lee Rivers Mobley1, Sujha Subramanian, Julia Koschinsky, H E Frech, Laurel Clayton Trantham, Luc Anselin.   

Abstract

OBJECTIVE: To determine whether Medicare managed care penetration impacted the diffusion of endoscopy services (sigmoidoscopy, colonoscopy) among the fee-for-service (FFS) Medicare population during 2001-2006.
METHODS: We model utilization rates for colonoscopy or sigmoidoscopy as impacted by both market supply and demand factors. We use spatial regression to perform ecological analysis of county-area utilization rates over two time intervals (2001-2003, 2004-2006) following Medicare benefits expansion in 2001 to cover colonoscopy for persons of average risk. We examine each technology in separate cross-sectional regressions estimated over early and later periods to assess differential effects on diffusion over time. We discuss selection factors in managed care markets and how failure to control perfectly for market selection might impact our managed care spillover estimates.
RESULTS: Areas with worse socioeconomic conditions have lower utilization rates, especially for colonoscopy. Holding constant statistically the socioeconomic factors, we find that managed care spillover effects onto FFS Medicare utilization rates are negative for colonoscopy and positive for sigmoidoscopy. The spatial lag estimates are conservative and interpreted as a lower bound on true effects. Our findings suggest that managed care presence fostered persistence of the older technology during a time when it was rapidly being replaced by the newer technology. © Health Research and Educational Trust.

Entities:  

Mesh:

Year:  2011        PMID: 22092022      PMCID: PMC3227000          DOI: 10.1111/j.1475-6773.2011.01301.x

Source DB:  PubMed          Journal:  Health Serv Res        ISSN: 0017-9124            Impact factor:   3.402


  31 in total

1.  Colonoscopy vs sigmoidoscopy screening: getting it right.

Authors:  Alfred I Neugut; Benjamin Lebwohl
Journal:  JAMA       Date:  2010-07-28       Impact factor: 56.272

2.  Market for colorectal cancer screening by endoscopy in the United States.

Authors:  Florence K Tangka; Noelle-Angelique M Molinari; Sajal K Chattopadhyay; Laura C Seeff
Journal:  Am J Prev Med       Date:  2005-07       Impact factor: 5.043

3.  Does Medicare coverage of colonoscopy reduce racial/ethnic disparities in cancer screening among the elderly?

Authors:  Ya-Chen Tina Shih; Lirong Zhao; Linda S Elting
Journal:  Health Aff (Millwood)       Date:  2006 Jul-Aug       Impact factor: 6.301

4.  Trends in colonoscopy for colorectal cancer screening.

Authors:  Kathryn A Phillips; Su-Ying Liang; Uri Ladabaum; Jennifer Haas; Karla Kerlikowske; David Lieberman; Robert Hiatt; Mika Nagamine; Stephanie L Van Bebber
Journal:  Med Care       Date:  2007-02       Impact factor: 2.983

5.  Improving colorectal cancer screening through research in primary care settings.

Authors:  Carrie N Klabunde; David Lanier; Helen I Meissner; Erica S Breslau; Martin L Brown
Journal:  Med Care       Date:  2008-09       Impact factor: 2.983

6.  Efficacy, effectiveness and cost-effectiveness of endoscopic screening methods.

Authors:  H Brenner
Journal:  Z Gastroenterol       Date:  2008-04       Impact factor: 2.000

7.  Managed care plan performance since 1980. A literature analysis.

Authors:  R H Miller; H S Luft
Journal:  JAMA       Date:  1994-05-18       Impact factor: 56.272

8.  Overuse of screening colonoscopy in the Medicare population.

Authors:  James S Goodwin; Amanpal Singh; Nischita Reddy; Taylor S Riall; Yong-Fang Kuo
Journal:  Arch Intern Med       Date:  2011-05-09

Review 9.  Screening for colorectal cancer in adults at average risk: a summary of the evidence for the U.S. Preventive Services Task Force.

Authors:  Michael Pignone; Melissa Rich; Steven M Teutsch; Alfred O Berg; Kathleen N Lohr
Journal:  Ann Intern Med       Date:  2002-07-16       Impact factor: 25.391

10.  Colonoscopy in the office setting is safe, and financially sound ... for now.

Authors:  Martin A Luchtefeld; Donald G Kim
Journal:  Dis Colon Rectum       Date:  2006-03       Impact factor: 4.585

View more
  8 in total

1.  What Happened to Disparities in CRC Screening Among FFS Medicare Enrollees Following Medicare Modernization?

Authors:  Lee R Mobley; Tzy-Mey Kuo; Mei Zhou; Yamisha Rutherford; Seth Meador; Julia Koschinsky
Journal:  J Racial Ethn Health Disparities       Date:  2018-09-19

2.  Breast cancer screening, area deprivation, and later-stage breast cancer in Appalachia: does geography matter?

Authors:  Roger T Anderson; Tse-Chang Yang; Stephen A Matthews; Fabian Camacho; Teresa Kern; Heath B Mackley; Gretchen Kimmick; Christopher Louis; Eugene Lengerich; Nengliang Yao
Journal:  Health Serv Res       Date:  2013-09-30       Impact factor: 3.402

3.  Spatial Sufficiency of 5% Medicare Standard Analytic Files.

Authors:  Lee R Mobley
Journal:  Spat Demogr       Date:  2015-05-14

4.  Geographic disparities in late-stage cancer diagnosis: multilevel factors and spatial interactions.

Authors:  Lee R Mobley; Tzy-Mey May Kuo; Lisa Watson; G Gordon Brown
Journal:  Health Place       Date:  2012-06-26       Impact factor: 4.078

5.  United States Health Policies and Late-stage Breast and colorectal cancer diagnosis: Why such disparities by age?

Authors:  Lee R Mobley; Tzy-Mey Kuo
Journal:  Health Econ Rev       Date:  2015-07-15

6.  Macro-level factors impacting geographic disparities in cancer screening.

Authors:  Lee R Mobley; Tzy-Mey Kuo; Jeffrey Traczynski; Victoria Udalova; H E Frech
Journal:  Health Econ Rev       Date:  2014-08-20

7.  Geographic and Demographic Disparities in Late-stage Breast and Colorectal Cancer Diagnoses Across the US.

Authors:  Lee R Mobley; Tzy-Mey May Kuo
Journal:  AIMS Public Health       Date:  2015-08-28

8.  Medicare modernization and diffusion of endoscopy in FFS medicare.

Authors:  Lee R Mobley; Pedro Amaral; Tzy-Mey Kuo; Mei Zhou; Srimoyee Bose
Journal:  Health Econ Rev       Date:  2017-03-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.